Management of minor head injury: The value of early computed tomography and serum protein S-100 measurements

Journal of Clinical Neuroscience

Volumn 4, Issue 1, 1997, Pages 29-33

  Ingebrigtsen, Tor ^a   Romner, Bertil ^a   Trumpy, Jens Hugo ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Brain injury; Computed tomography; Minor head injury; Protein S 100

Indexed keywords

EID: 0002248657     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(97)90007-2     Document Type: Article

References (34)

1. Nestvold K, Lundar T, Blikra G, Lønnum A. Head injuries during one year in a central hospital in Norway: A prospective study. Neuroepidemiology 1988; 7: 134-144.
2. Edna TH. Disability 3-5 years after minor head injury. J Oslo City Hosp 1987; 37: 41-48.
3. Rockswold GL, Leonard PR, Naquib MG. Analysis of management in thirty three closed head injury patients who 'talked and deteriorated'. Neurosurgery 1987; 21: 51-55.
4. Eide PK, Tysnes O-B. The outcome after head injury in patients with radiologically demonstrated brain contusion. Tidsskr Nor Laegeforen 1993; 113: 1227-1229.
5. Sabers A, Heyn J, Karle A, Pakkenberg H. Computed tomography in brain concussion. Ugeskr Læg 1988; 150: 1161-1163.
6. Oppenheimer DR. Microscopic lesions in the brain following head injury. J Neurol Neurosurg Psychiatry 1968; 31: 299-306.
7. Povlishock JT, Becker DP, Cheng CLY, Vaughan GW. Axonal change in minor head injury. J Neuropath Exp Neurol 1983; 42: 225-242.
8. Rabow L, Hedman G. Creatine kinase BB activity after head trauma related to outcome. Acta Neurochir (Wien) 1985; 76: 137-139.
9. Skogseid IM, Nordby HK, Urdal P, Paus E, Lilieaas F. Increased serum creatine kinase BB and neuron-specific enolase following head injury indicates brain damage. Acta Neurochir 1992; 115: 106-111.
10. Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum levels of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry 1995; 59: 103-104.
11. Jensen R, Marshak DR, Anderson C, Lukas TJ, Watterson DM. Characterization of human brain S-100 protein fraction: amino acid sequence of S100β. J Neurochem 1985; 45: 700-705.
12. Fagnart OC, Sindic CMJ, Laterre C. Particle counting immunoassay of S-100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 1988; 34: 1387-1391.
13. Shackford SR, Wald SL, Ross SE, et al. The clinical utility of computed tomographic scanning and neurologic examination in the management of patients with minor head injuries. J Trauma 1992; 33: 385-394.
14. Stein SC, Ross SE. Mild head injury: a plea for routine early CT scanning. J Trauma 1992; 33: 11-13.
15. Livingston DH, Loder PA, Hunt CD. Minimal head injury: is admission necessary? Am Surg 1991; 57: 14-17.
16. Kvarnes TL, Trumpy JH. Extradural haematoma. Report of 132 cases. Acta Neurochir (Wien) 1978; 41: 223-231.
17. Teasdale GM, Murray G, Anderson E, Mendelow AD, MacMillan R, Jennet B. Risks of acute traumatic intracranial haematoma in children and adults: implications for managing head injuries. Br Med J 1990; 300: 363-367.
18. Galbraiht S, Mendelow AD, Jennet B. Skull fracture in head injury. Lancet 1981; ii: 791-795.
19. Mendelow AD, Campbell DA, Jefrey RR, et al. Admission after mild head injury: benefits and costs. Br Med J 1982; 285: 1530-1532.
20. Miller JD, Murray LS, Teasdale GM. Development of a traumatic intracranial hematoma after a 'minor' head injury. Neurosurgery 1990; 27: 669-673.
21. Klauber MR, Marshall LF, Leurssen PG, Frankowski R, Tabbador K, Eisenberg HM. Determinants of head injury mortality: importance of the low-risk patient. Neurosurgery 1989; 24: 31-36.
22. Rutherford WH, Merret JD, McDonald JR. Symptoms at one year following concussion from minor head injury. Injury 1979; 10: 225-230.
23. Kelly R. The post-traumatic syndrome. Roy Soc Med 1981; 74: 242-244.
24. Middelboe T, Andersen HS, Birket-Smith M, Friis ML. Minor head injury: impact on general health after 1 year. A prospective follow-up study. Acta Neurol Scand 1992; 85: 5-9.
25. Jenkins A, Teasdale G, Hadley MDM, Macpherson P, Rowan JO. Brain lesions detected by magnetic resonance imaging in mild and severe head injury. Lancet 1986; 23: 445-446.
26. Levin HS, Amparo E, Eisenberg HM, Williams DH, High WM, McArdle CB, Weiner RL. Magnetic resonance imaging and computerized tomography in relation to neurobehavioral sequelae of mild and moderate head injuries. J Neurosurg 1987; 66: 706-713.
27. Michetti F, Massaro A, Murazio M. The nervous system specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 1979; 11: 247-251.
28. Michetti F, Massaro A, Russo G, Rigon G. The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the central nervous system. J Neurol Sci 1980; 44: 259-263.
29. Mokuno K, Kato K, Kawai K, Matsuoka Y, Yanagi T, Sobue I. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 1983; 60: 443-451.
30. Kato K, Nakajima T, Ishiguro Y, Matsutani T. Sensitive enzyme immunoassay for S-100 protein: determination in human cerebrospinal fluid. Biomed Res 1982; 3: 24-28.
31. Aurell A, Rosengren LE, Karlsson B, Olsson J-E, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke 1991; 22: 1254-1258.
32. Sindic CJM, Chalon MP, Cambiaso CL, Laterre EC, Masson PL. Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1982; 45: 1130-1135.
33. Persson L, Hårdemark H, Edner G, Ronne E, Mendel-Hartvig I, Påhlman S. S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: a potential marker of brain damage. Acta Neurochir 1988; 93: 116-122.
34. Persson L, Hårdemark HG, Gustafsson J, Rundström G, Mendel-Hartvig I, Esscher T, Påhlman S. S-100 protein and neuron-specific-enolase in cerebrospinal fluid and serum. Markers of cell damage in human central nervous tissue. Stroke 1987; 18: 911-918.